629 related articles for article (PubMed ID: 21692821)
1. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
2. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
[TBL] [Abstract][Full Text] [Related]
3. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
[TBL] [Abstract][Full Text] [Related]
7. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
Vleggaar FP; Lutgens MW; Claessen MM
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
Zheng HH; Jiang XL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
[TBL] [Abstract][Full Text] [Related]
9. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
[TBL] [Abstract][Full Text] [Related]
10. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
12. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Zhang R; Lauwers GY; Choi WT
J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
[TBL] [Abstract][Full Text] [Related]
13. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
Imam MH; Thackeray EW; Lindor KD
Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
[TBL] [Abstract][Full Text] [Related]
14. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
16. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
18. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
19. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]